Sales Support:
sales@worldwidemarketreports.com
U.S. :+1 415 871 0703
U.K. :+44-203-289-4040
AUS. : +61-2-4786-0457
INDIA :+91-848-285-0837
Menu Icon Close Icon
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global COPD Drugs Market: Analysis By Drug Type (Combination Therapy, Anticholinergics, Beta-Agonist, Inhaled Corticosteroids, Others), Pipeline Drugs, By Region, By Country (2019 Edition)- Forecast to 2023

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of COPD Drugs Market. The report analyses the COPD Drugs Market By Drug Type (Combination Therapy Drugs, Anticholinergics, Beta-Agonist, Inhaled Corticosteroids, and Others). The report analyses the COPD Drugs Market, By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India) for the historical period of 2013-2017 and the forecast period of 2018-2023. This report also includes pipeline analysis for few COPD drugs.

According to Azoth Analytics research report "Global COPD Drugs Market: Analysis By Drug Type (Combination Therapy Drugs, Anticholinergics, Beta-Agonist, Inhaled Corticosteroids, Others), Pipeline Drugs, By Region, By Country (2019 Edition): Forecast to 2023 - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India)", the COPD drugs market is projected to display robust growth represented by a CAGR of 2.47% during 2018 - 2023.

Over the recent years, COPD Drugs market has been witnessing growth on account of several driving factors including growing prevalence of COPD associated diseases, rising patient population, and increase in availability of novel combination therapy drugs. Moreover, increasing awareness regarding COPD, high smoking prevalence, rising pollution level, growing medical spending, favorable government initiatives, public private partnership have been driving the market growth. In addition, rising geriatric population, increasing global healthcare expenditure and technological advancements in pharmaceuticals research, and growing scope in middle and low income countries with large patient population is anticipated to impel the market growth of the COPD drugs market. However, growing portfolio of generic COPD drugs, and patent expiration of few innovator drugs in upcoming years are expected to hinder the market performance during forecasted period.

In this research report, the market is segmented on the basis of drug type. By drug type, the combination therapy COPD drugs are predicted to hold their dominant position in the market, especially LABA/LAMA and triple combination ICS/LABA/LAMA market is expected to gain more traction in forecasted period. Amongst the regions, North America accounts for the largest regional share in the global COPD drugs market in 2017. The largest share of North America is attributed to presence of enormous number of patient base and more emphasis towards prescribed branded drugs.

The report titled "Global COPD Drugs Market: Analysis By Drug Type (Combination Therapy Drugs, Anticholinergics, Beta-Agonist, Inhaled Corticosteroids, Others), Pipeline Drugs, By Region, By Country (2019 Edition): Forecast to 2023 - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India" has covered and analysed the potential of COPD drugs market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the COPD drugs market. Additionally, the report also highlights market entry strategies for various companies across the globe along with pipeline and product analysis.
Scope of the Report

Global COPD Drugs Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• COPD Drugs Market- Size, Growth, Forecast
• Analysis By Drug Type - Combination Therapy COPD Drugs, Anticholinergics COPD Drugs, Beta-Agonist COPD Drugs, Inhaled Corticosteroids COPD Drugs, and Other COPD Drugs.

Regional COPD Drugs Market - North America, Europe, Asia Pacific, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• COPD Drugs Market- Size, Growth, Forecast
• Analysis By Drug Type - Combination Therapy COPD Drugs, Anticholinergics COPD Drugs, Beta-Agonist COPD Drugs, Inhaled Corticosteroids COPD Drugs, and Other COPD Drugs.

Country Analysis - U.S., Canada, Germany, U.K, France, Italy, China, Japan, India (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• COPD Drugs Market- Size, Growth, Forecast
• Analysis By Drug Type - Combination Therapy COPD Drugs, Anticholinergics COPD Drugs, Beta-Agonist COPD Drugs, Inhaled Corticosteroids COPD Drugs, Other COPD Drugs.

Other Report Highlights
• Pipeline Analysis- PT010, Duaklir, Nemiralisib, Danirixin.
• Product Analysis.
• Market Dynamics - Drivers and Restraints.
• Market Trends.
• Porter Five Forces Analysis.
• SWOT Analysis.
• Company Analysis - Glaxo SmithKline, AstraZeneca, Boehringer-Ingelheim, TEVA Pharmaceuticals, Chiesi Pharmaceuticals, Novartis, Merck, Cipla, Mylan, Vectura, Sunovion

Customization of the Report
The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research. 

Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendation
3.1 Invest in COPD Generic Drugs
3.2 Asia Pacific Region To Witness The Fastest Growth

4. COPD Drugs Products Outlook

5. Global COPD Drugs Market: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)

6. Global COPD Drugs Market: Segmental Analysis
6.1 Global COPD Drugs Market Size, By Drug Type: Breakdown (%)
6.1.1 Global COPD Drugs Market Size, By Drug Type, 2017 (%)
6.1.2 Global COPD Drugs Market Size, By Drug Type, 2023 (%)
6.2 Global Combination Therapy COPD Drugs Market  Size, By Value (2013-2023)
6.3 Global Anticholinergics COPD Drugs Market Size, By Value (2013-2023)
6.4 Global Beta- Agonist COPD Drugs Market Size, By Value (2013-2023)
6.5 Global ICS COPD Drugs Market Size, By Value (2013-2023)
6.6 Global Other COPD Drugs Market Size, By Value (2013-2023)
6.6 Global COPD Drugs: Market Attractiveness, By Drug Type

7. Global COPD Drugs Market: Regional Analysis
7.1 Global COPD Drugs Market Size, By Region : Breakdown (%)
7.1.1 Global COPD Drugs Market Size, By Region, 2017 (%)
7.1.2 Global COPD Drugs Market Size, By Region, 2023 (%)

8. North America COPD Drugs Market: Growth and Forecast
8.1 North America COPD Drugs Market: Segmental Analysis
8.2 North America COPD Drugs Market Size, By Drug Type: Breakdown (%)
8.2.1 North America COPD Drugs Market Size, By Drug Type, 2017 (%)
8.2.2 North America COPD Drugs Market Size, By Drug Type, 2023 (%)
8.3 North America Combination Therapy COPD Drugs Market  Size, By Value (2013-2023)
8.4 North America  Anticholinergics COPD Drugs Market Size, By Value (2013-2023)
8.5 North America Beta- Agonist COPD Drugs Market Size, By Value (2013-2023)
8.6 North America ICS COPD Drugs Market Size, By Value (2013-2023)
8.7 North America Other COPD Drugs Market Size, By Value (2013-2023)
8.9 North America COPD Drugs Market: Country Analysis (U.S and Canada)
8.9.1 U.S COPD Drugs Market, By Value (2013-2023)
8.9.2 U.S COPD Drugs Market, By Drug Type, By Value (2013-2023)
8.9.3 Canada COPD Drugs Market, By Value (2013-2023)
8.9.4 Canada COPD Drugs Market, By Drug Type, By Value (2013-2023)

9. Europe COPD Drugs Market: Growth and Forecast
9.1 Europe COPD Drugs Market: Segmental Analysis
9.2 Europe COPD Drugs Market Size, By Drug Type: Breakdown (%)
9.1.2 Europe COPD Drugs Market Size, By Drug Type, 2017 (%)
9.1.3 Europe COPD Drugs Market Size, By Drug Type, 2023 (%)
9.3 Europe Combination Therapy COPD Drugs Market  Size, By Value (2013-2023)
9.4 Europe America  Anticholinergics COPD Drugs Market Size, By Value (2013-2023)
9.5 Europe America Beta- Agonist COPD Drugs Market Size, By Value (2013-2023)
9.6 Europe America ICS COPD Drugs Market Size, By Value (2013-2023)
9.7 Europe America Other COPD Drugs Market Size, By Value (2013-2023)
9.8 Europe COPD Drugs Market: Country Analysis (Germany, France, U.K, Italy)
9.8.1 Germany COPD Drugs Market, By Value (2013-2023)
9.8.2 Germany COPD Drugs Market, By Drug Type, By Value (2013-2023)
9.8.4 France COPD Drugs Market, By Value (2013-2023)
9.8.5 France COPD Drugs Market, By Drug Type, By Value (2013-2023)
9.8.7 UK COPD Drugs Market, By Value (2013-2023)
9.8.6 UK COPD Drugs Market, By Drug Type, By Value (2013-2023)
9.8.7 Italy COPD Drugs Market, By Value (2013-2023)
9.8.8 Italy COPD Drugs Market, By Drug Type, By Value (2013-2023)

10. APAC COPD Drugs Market: Growth and Forecast
10.1 APAC COPD Drugs Market: Segmental Analysis
10.2 APAC COPD Drugs Market Size, By Drug Type: Breakdown (%)
10.2.1 APAC COPD Drugs Market Size, By Drug Type, 2017 (%)
10.2.2 APAC COPD Drugs Market Size, By Drug Type, 2023 (%)
10.3 APAC Combination Therapy COPD Drugs Market  Size, By Value (2013-2023)
10.4 APAC Anticholinergics COPD Drugs Market Size, By Value (2013-2023)
10.5 APAC Beta- Agonist COPD Drugs Market Size, By Value (2013-2023)
10.6 APAC ICS COPD Drugs Market Size, By Value (2013-2023)
10.7 APAC Other COPD Drugs Market Size, By Value (2013-2023)
10.8 APAC COPD Drugs Market: Country Analysis (China, Japan, and India)
10.8.1 China COPD Drugs Market, By Value (2013-2023)
10.8.2 China COPD Drugs Market, By Drug Type, By Value (2013-2023)
10.8.3 Japan COPD Drugs Market, By Value (2013-2023)
10.8.4 Japan COPD Drugs Market, By Drug Type, By Value (2013-2023)
10.8.5 India COPD Drugs Market, By Value (2013-2023)
10.8.6 India COPD Drugs Market, By Drug Type, By Value (2013-2023)

11. ROW COPD Drugs Market: Growth and Forecast
11.1 ROW COPD Drugs Market: Segmental Analysis
11.2 ROW COPD Drugs Market Size, By Drug Type: Breakdown (%)
11.1.1 ROW COPD Drugs Market Size, By Drug Type, 2017 (%)
11.1.2 ROW COPD Drugs Market Size, By Drug Type, 2023 (%)
11.3 ROW Combination Therapy COPD Drugs Market  Size, By Value (2013-2023)
11.4 ROW Anticholinergics COPD Drugs Market Size, By Value (2013-2023)
11.5 ROW Beta- Agonist COPD Drugs Market Size, By Value (2013-2023)
11.6 ROW ICS COPD Drugs Market Size, By Value (2013-2023)
11.7 ROW Other COPD Drugs Market Size, By Value (2013-2023)

12. Global COPD Drugs Market: Pipeline Analysis

13. Global COPD Drugs Market: Market Dynamics
13.1 Global COPD Drugs Market: Drivers
13.2 Global COPD Drugs Market: Restrains
13.3 Global COPD Drugs Market: Trends
13.4 Global COPD Drugs Market: Product Benchmarking
13.5 Global COPD Drugs Market: Sales Analysis, By Company

14. Porter Five Force Analysis

15. SWOT Analysis

16. Company Profiles
16.1 GSK 
16.2 AstraZeneca 
16.3 Boehringer-Ingelheim
16.4 Teva Pharmaceuticals 
16.5 Chiesi Farmaceutici S.p.A.
16.6 Novartis 
16.7 Cipla 
16.8 Mylan 
16.9 Vectura Group Plc,
16.10 Sunovion
Healthcare and Pharmaceuticals

mRNA Vaccine Drugs Development Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)

  Price : US$ 3,500   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 132
Medical Devices

Asia Pacific Oxygen Therapy Equipment Market Size, Share, Trends & Analysis by Product (Oxygen Source, Delivery Devices), by Portability (Stationary, Portable), by Application (COPD, Asthma, Cystic Fibrosis, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Pneumonia, Others), by End User (Hospital, Home Care) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3,280   Date : Jul 2024
  Category : Medical Devices   Pages : 188
Medical Devices

Europe Oxygen Therapy Equipment Market Size, Share, Trends & Analysis by Product (Oxygen Source, Delivery Devices), by Portability (Stationary, Portable), by Application (COPD, Asthma, Cystic Fibrosis, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Pneumonia, Others), by End User (Hospital, Home Care) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3,280   Date : Jul 2024
  Category : Medical Devices   Pages : 193
Medical Devices

North America Oxygen Therapy Equipment Market Size, Share, Trends & Analysis by Product (Oxygen Source, Delivery Devices), by Portability (Stationary, Portable), by Application (COPD, Asthma, Cystic Fibrosis, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Pneumonia, Others), by End User (Hospital, Home Care) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3,280   Date : Jul 2024
  Category : Medical Devices   Pages : 187
Medical Devices

Global Oxygen Therapy Equipment Market Size, Share, Trends & Analysis by Product (Oxygen Source, Delivery Devices), by Portability (Stationary, Portable), by Application (COPD, Asthma, Cystic Fibrosis, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Pneumonia, Others), by End User (Hospital, Home Care) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3,580   Date : Jul 2024
  Category : Medical Devices   Pages : 210

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.

Related Reports

MRNA Vaccine Drugs Development Services Market Size And Share Analysis - Growth Trends And Fo...
View More
Asia Pacific Oxygen Therapy Equipment Market Size, Share, Trends & Analysis By Product (Oxyge...
View More
Europe Oxygen Therapy Equipment Market Size, Share, Trends & Analysis By Product (Oxygen Sour...
View More
North America Oxygen Therapy Equipment Market Size, Share, Trends & Analysis By Product (Oxyg...
View More
Global Oxygen Therapy Equipment Market Size, Share, Trends & Analysis By Product (Oxygen Sour...
View More

Trusted Clients
A-T- Kearney.png
AbbVie.png
Agrinos.png
AIF-Metrics.png
Akzo-Nobel.jpg
Alfi-GMBH.png
Allergan.png
Almasra-Scientific-Bureau.jpg
ALPMA.jpg
Americana-Foods.png
ANP.png
Aptar-Group-Germany.jpg
asahi-kasei.png
ATC.png
atlas-servair.jpg
ATOS.png
Avalon.png
biofishency.png
biomx.png
borealisgroup.png
Cape-Peninsula.png
CBRE.png
Cennerv-Pharma.jpg
Clearponds.png
Compass-Group.png
Cortag-Industria.png
Covis-Pharma.jpg
DAIMLER-AG.jpg
Edipresse-Media.jpg
Epson.png
Evonik-Industries-AG.png
ExcelSource.png
Fingo.png
Firstkind.png
FLM-Foodingredients.png
Freudenberg.png
Fueltrax.jpg
Fugro-International.png
Fuji-Films.png
Funky-Sound-Studio.png
GALTWAY.png
Gartner.png
GBSC.png
Global-Information.jpg
Hanwha-Total-Petrochemical.png
Hebrew.png
Horiba-Mira.png
Hunter-and-Co-Investments.png
Hyosung.png
Hyssopus-Organics.jpg
IBSA.png
Ideagen.png
IMS.png
InSinkErator.png
Intas-Pharma.png
IntelMed-Sarl.png
Interdiligence-Consulting.png
Israel-Shopyards.png
Johnsons-Controls.png
kakaxi.jpg
KORDSA.png
kotra.png
KPMG.png
lantmannen.png
LEK.png
LG.jpg
Makuri-Technology.jpg
Mallinckrodt.png
Mappo.png
Maprimed.jpg
mcns.jpg
MED-EL.png
Mehr-Azin-Pouya-Sahand.png
Molkerei-Ammerland-eG.png
Monty-Holding.jpg
mpmaterials.png
Mundipharma.png
Nasco.png
Nitto.png
Nouryon.png
NOXTAK.png
Oskars.png
Paidotribo.png
Parnell-Pharmaceuticals.png
Podravka.png
ppg.png
Privi.png
Publicis Groupe.png
Qvetech.jpg
R3P.jpg
Samsung.png
Sapient.png
SEW-EURODRIVE.png
Shivananda.jpg
Silver-Clouds.png
SMIT.jpg
SOLVIAS.png
Spectrum.png
SR-Instruments-Oy.png
Star-Seed.png
Stryker -ENT.png
Synjenta.png
Terumo-Corp.png
TherOzone.png
Toshiba.png
TT-Electronics.png
umbc.edu.png
Vard.jpg
Vital-Xense.png
Walraven.png
Wlgore.png
Woodmac.png
WWF-UK.png
ZENOAQ.png
Zuellig-Pharma.png
Contact us

sales@worldwidemarketreports.com

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

phoneiconU.S. : +1 415 871 0703

phoneiconU.K. : +44-203-289-4040

phoneiconAUS. :+61-2-4786-0457

phoneiconIndia :+91-848-285-0837

Menu
Quick Links
Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved